Education Library

Resources for Health Care Professionals

Condition

Audience

Topic

Type

Achieving >70% AMICS Survival: Insights From National Cardiogenic Shock Initiative Study

October 27, 2020

William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock. 

Results From PROTECT III, the Largest Prospective Multi-Center Single-Arm Study

October 27, 2020

Jeffrey Moses, MD, presents results from PROTECT III, the largest prospective study of Impella for high-risk PCI in the real world.

Review RECOVER III and RECOVER IV Studies

October 27, 2020

William O’Neill, MD, reviews RECOVER III study data and introduces the RECOVER IV study.

Impella 5.5® with SmartAssist® Tip-to-Toe

October 22, 2020

Kevin Ray, Global Impella® Trainer, provides a tip-to-toe review of the Impella 5.5 with SmartAssist.

Rapid and Safe Adoption of the New Single Access Technique

October 20, 2020

Duane Pinto, MD, MPH discusses the new single access technique, designed to avoid an additional arterial access, and reduce associated complications as well as make the procedure more rapid

What Causes Thrombus Formation Among Blood-Contacting Medical Devices and What Can Be Done to Prevent Thrombosis?

October 9, 2020

Efforts to prevent thrombus formation among blood-contacting medical devices such as the Impella® heart pump include administration of anticoagulant medications such as heparin and direct thrombin inhibitors

Your Destination for TCT 2020 Event Resources

October 6, 2020

TCT Connect highlighted the benefits of a more complete revascularization with Impella heart pumps in high-risk PCI patients and the value of Impella protocol-based treatment for survival and native heart recovery in cardiogenic shock patients.

Impella® Experience in the UK: Clinical Utility, Indications, and Outcomes

September 30, 2020

Vasileios Panoulas, MD, and colleagues assess the clinical utility, indications, and outcomes of the Impella platform in their tertiary center in London, UK.

Impella 5.5® with SmartAssist®: Echocardiography for Real-time Positioning

September 28, 2020

Learn when and how to use echocardiography to visualize in real-time the relationship of the Impella 5.5 with SmartAssist to structures within the left ventricle.

Transferring to a Backup AIC

September 25, 2020

This quick skills video demonstrates the procedure for transferring Impella® support from one Automated Impella Controller (AIC) to another AIC.

Optimal Target MAP in Post-Cardiac Arrest AMI Shock

September 22, 2020

Ameloot et al. report significant reduction in myocardial injury with target MAP between 80/85 and 100 mmHg in post-cardiac arrest patients with shock after AMI.

Influence of Impella® Timing and Predicted Mortality Risk in Cardiogenic Shock

September 16, 2020

Prof. Andreas Schäfer, MD discusses standardized use of Impella in AMICS and predicted mortality rates, timing of implantation, and patient selection based on predicted risk.

Better Than Anticipated Survival with Impella CP® and ECMO in Cardiogenic Shock

September 9, 2020

Steven P. Keller, MD, examines different mechanical circulatory support strategies for left ventricular unloading in ECMO supported patients in cardiogenic shock.

Treating Protected PCI & Impella Therapies as Essential During COVID-19

September 1, 2020

Shami Mahmud, MD, FSCAI, discusses high-risk PCI (HRPCI) in the era of COVID-19.

Comparing Impella® to ECMO in AMICS

August 30, 2020

Lemor et al. demonstrate better clinical outcomes, fewer complications, shorter hospital stay, and lower cost with Impella compared to ECMO in AMICS.

NPS-1674